02:28 PM EDT, 04/03/2024 (MT Newswires) -- View (VIEW) said late Tuesday that it received approval from key shareholders for a balance sheet restructuring plan.

Shares slumped about 60%, with intraday trading volume at over 1.1 million versus a daily average of about 177,000.

FibroGen ( FGEN ) reported late Tuesday "encouraging" data from a Fortis Therapeutics-sponsored phase 1 study of FG-3246 in patients with metastatic castration-resistant prostate cancer.

Shares sank 28% as intraday trading volume soared to more than 8.74 million from a daily average of about 2.64 million.

Casa Systems ( CASA ) shares plunged 80% after it began a court-supervised Chapter 11 sale of its businesses.

More than 37 million shares traded intraday compared with a daily average of about 292,000.

Price: 0.45, Change: -0.65, Percent Change: -59.09